Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19

被引：0
|
作者：
Moingeon, Philippe [1 ]
Desvaux, Emiko [1 ]
Hubert, Sandra [1 ]
Swindle, Jack [1 ]
Laigle, Laurence [1 ]
Guedj, Mickael [1 ]
机构：
[1] Servier, Res & Dev, Suresnes, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Drugs for immune modulation; inflammatory molecules; modelling; tissue damage and repair; viral infections;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-1004
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [1] Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
    Desvaux, Emiko
    Hamon, Antoine
    Hubert, Sandra
    Boudjeniba, Cheima
    Chassagnol, Bastien
    Swindle, Jack
    Aussy, Audrey
    Laigle, Laurence
    Laplume, Jessica
    Soret, Perrine
    Jean-Francois, Pierre
    Dupin-Roger, Isabelle
    Guedj, Mickael
    Moingeon, Philippe
    PLOS ONE, 2021, 16 (07):
  • [2] In silico drug repurposing in COVID-19: A network-based analysis
    Sibilio, Pasquale
    Bini, Simone
    Fiscon, Giulia
    Sponziello, Marialuisa
    Conte, Federica
    Pecce, Valeria
    Durante, Cosimo
    Paci, Paola
    Falcone, Rosa
    Norata, Giuseppe Danilo
    Farina, Lorenzo
    Verrienti, Antonella
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [3] SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
    Fiscon, Giulia
    Conte, Federica
    Farina, Lorenzo
    Paci, Paola
    PLOS COMPUTATIONAL BIOLOGY, 2021, 17 (02)
  • [4] Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages
    Wang, Xin
    Wang, Han
    Yin, Guosheng
    Zhang, Yan Dora
    HELIYON, 2023, 9 (03)
  • [5] DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19
    Su, Yinchun
    Wu, Jiashuo
    Li, Xiangmei
    Li, Ji
    Zhao, Xilong
    Pan, Bingyue
    Huang, Junling
    Kong, Qingfei
    Han, Junwei
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 159
  • [6] Network analytics for drug repurposing in COVID-19
    Siminea, Nicoleta
    Popescu, Victor
    Martin, Jose Angel Sanchez
    Florea, Daniela
    Gavril, Georgiana
    Gheorghe, Ana-Maria
    Itcus, Corina
    Kanhaiya, Krishna
    Pacioglu, Octavian
    Popa, Laura Lona
    Trandafir, Romica
    Tusa, Maria Iris
    Sidoroff, Manuela
    Paun, Mihaela
    Czeizler, Eugen
    Paun, Andrei
    Petre, Ion
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (01)
  • [7] Drug repurposing for COVID-19: Approaches, challenges and promising candidates
    Ng, Yan Ling
    Salim, Cyrill Kafi
    Chu, Justin Jang Hann
    PHARMACOLOGY & THERAPEUTICS, 2021, 228
  • [8] Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
    Debarati Paul
    Debadrita Basu
    Shubhra Ghosh Dastidar
    Journal of Molecular Modeling, 2021, 27
  • [9] Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
    Paul, Debarati
    Basu, Debadrita
    Ghosh Dastidar, Shubhra
    JOURNAL OF MOLECULAR MODELING, 2021, 27 (05)
  • [10] Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
    Mirabelli, Carmen
    Wotring, Jesse W.
    Zhang, Charles J.
    McCarty, Sean M.
    Fursmidt, Reid
    Pretto, Carla D.
    Qiao, Yuanyuan
    Zhang, Yuping
    Frum, Tristan
    Kadambi, Namrata S.
    Amin, Anya T.
    O'Meara, Teresa R.
    Spence, Jason R.
    Huang, Jessie
    Alysandratos, Konstantinos D.
    Kotton, Darrell N.
    Handelman, Samuel K.
    Wobus, Christiane E.
    Weatherwax, Kevin J.
    Mashour, George A.
    O'Meara, Matthew J.
    Chinnaiyan, Arul M.
    Sexton, Jonathan Z.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (36)
12345